Cargando…

Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies

About 5% of B cells in healthy mice and humans are allelically or isotypically included and hence co-express two different antibodies. In mice, dual antibody B cells (B(2R)) expand with systemic autoimmunity, co-express autoreactive and non-autoreactive antibodies, and participate in immune response...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Jacob N., Boackle, Susan A., Taitano, Sophina H., Sang, Allison, Lang, Julie, Kelly, Margot, Rahkola, Jeremy T., Miranda, Anjelica M., Sheridan, Ryan M., Thurman, Joshua M., Rao, V. Koneti, Torres, Raul M., Pelanda, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854503/
https://www.ncbi.nlm.nih.gov/pubmed/35185888
http://dx.doi.org/10.3389/fimmu.2022.795209
_version_ 1784653452793610240
author Peterson, Jacob N.
Boackle, Susan A.
Taitano, Sophina H.
Sang, Allison
Lang, Julie
Kelly, Margot
Rahkola, Jeremy T.
Miranda, Anjelica M.
Sheridan, Ryan M.
Thurman, Joshua M.
Rao, V. Koneti
Torres, Raul M.
Pelanda, Roberta
author_facet Peterson, Jacob N.
Boackle, Susan A.
Taitano, Sophina H.
Sang, Allison
Lang, Julie
Kelly, Margot
Rahkola, Jeremy T.
Miranda, Anjelica M.
Sheridan, Ryan M.
Thurman, Joshua M.
Rao, V. Koneti
Torres, Raul M.
Pelanda, Roberta
author_sort Peterson, Jacob N.
collection PubMed
description About 5% of B cells in healthy mice and humans are allelically or isotypically included and hence co-express two different antibodies. In mice, dual antibody B cells (B(2R)) expand with systemic autoimmunity, co-express autoreactive and non-autoreactive antibodies, and participate in immune responses, but this phenomenon is strain dependent. This study was developed with two goals: 1) to establish the contribution of TLR and IFN receptor signaling to the development of germinal center B cells that express two antibodies in MRL/lpr mice; and 2) to determine whether B(2R) B cells are increased and particularly activated in a subset of adult patients diagnosed with systemic lupus erythematosus (SLE). Results from the MRL/lpr studies indicate that the enhanced differentiation of dual-κ B cells into germinal center B cells is due to a heightened response to TLR7 and TLR9 signaling, further fueled by an increased response to type II IFN. To understand the clinical and translational implications of our observations in mouse B(2R) B cells, cohorts of SLE patients and healthy controls were recruited and evaluated for expression of dual BCRs. Results from flow cytometry and microscopy revealed supraphysiological frequencies of κ(+)λ(+) B(2R) cells in one fourth of the SLE patients. Abnormal numbers of κ(+)λ(+) B cells correlated with higher frequencies of activated naïve B cells and age-associated B cells, and a lower proportion of “B cells that are naïve IgD(+)” (BND). However, results from single cell V(D)J sequencing demonstrated that these high κ(+)λ(+) SLE patients harbored normal frequencies of κ(+)λ(+) and other B(2R) B cells. and we further show that their B cells were instead decorated by κ and λ VH4-34 autoantibodies. Thus, our findings indicate that elevated flow cytometric detection of isotypically-included B cells can identify patients with high titers of B cell-reactive VH4-34 autoantibodies and abnormal distribution of B cell subsets relevant to autoimmunity.
format Online
Article
Text
id pubmed-8854503
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88545032022-02-19 Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies Peterson, Jacob N. Boackle, Susan A. Taitano, Sophina H. Sang, Allison Lang, Julie Kelly, Margot Rahkola, Jeremy T. Miranda, Anjelica M. Sheridan, Ryan M. Thurman, Joshua M. Rao, V. Koneti Torres, Raul M. Pelanda, Roberta Front Immunol Immunology About 5% of B cells in healthy mice and humans are allelically or isotypically included and hence co-express two different antibodies. In mice, dual antibody B cells (B(2R)) expand with systemic autoimmunity, co-express autoreactive and non-autoreactive antibodies, and participate in immune responses, but this phenomenon is strain dependent. This study was developed with two goals: 1) to establish the contribution of TLR and IFN receptor signaling to the development of germinal center B cells that express two antibodies in MRL/lpr mice; and 2) to determine whether B(2R) B cells are increased and particularly activated in a subset of adult patients diagnosed with systemic lupus erythematosus (SLE). Results from the MRL/lpr studies indicate that the enhanced differentiation of dual-κ B cells into germinal center B cells is due to a heightened response to TLR7 and TLR9 signaling, further fueled by an increased response to type II IFN. To understand the clinical and translational implications of our observations in mouse B(2R) B cells, cohorts of SLE patients and healthy controls were recruited and evaluated for expression of dual BCRs. Results from flow cytometry and microscopy revealed supraphysiological frequencies of κ(+)λ(+) B(2R) cells in one fourth of the SLE patients. Abnormal numbers of κ(+)λ(+) B cells correlated with higher frequencies of activated naïve B cells and age-associated B cells, and a lower proportion of “B cells that are naïve IgD(+)” (BND). However, results from single cell V(D)J sequencing demonstrated that these high κ(+)λ(+) SLE patients harbored normal frequencies of κ(+)λ(+) and other B(2R) B cells. and we further show that their B cells were instead decorated by κ and λ VH4-34 autoantibodies. Thus, our findings indicate that elevated flow cytometric detection of isotypically-included B cells can identify patients with high titers of B cell-reactive VH4-34 autoantibodies and abnormal distribution of B cell subsets relevant to autoimmunity. Frontiers Media S.A. 2022-02-04 /pmc/articles/PMC8854503/ /pubmed/35185888 http://dx.doi.org/10.3389/fimmu.2022.795209 Text en Copyright © 2022 Peterson, Boackle, Taitano, Sang, Lang, Kelly, Rahkola, Miranda, Sheridan, Thurman, Rao, Torres and Pelanda https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Peterson, Jacob N.
Boackle, Susan A.
Taitano, Sophina H.
Sang, Allison
Lang, Julie
Kelly, Margot
Rahkola, Jeremy T.
Miranda, Anjelica M.
Sheridan, Ryan M.
Thurman, Joshua M.
Rao, V. Koneti
Torres, Raul M.
Pelanda, Roberta
Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies
title Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies
title_full Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies
title_fullStr Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies
title_full_unstemmed Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies
title_short Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies
title_sort elevated detection of dual antibody b cells identifies lupus patients with b cell-reactive vh4-34 autoantibodies
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854503/
https://www.ncbi.nlm.nih.gov/pubmed/35185888
http://dx.doi.org/10.3389/fimmu.2022.795209
work_keys_str_mv AT petersonjacobn elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT boacklesusana elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT taitanosophinah elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT sangallison elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT langjulie elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT kellymargot elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT rahkolajeremyt elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT mirandaanjelicam elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT sheridanryanm elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT thurmanjoshuam elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT raovkoneti elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT torresraulm elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies
AT pelandaroberta elevateddetectionofdualantibodybcellsidentifieslupuspatientswithbcellreactivevh434autoantibodies